Skip Navigation
  • Dana-Farber Cancer Institute is dedicated to fighting cancer through excellence in clinical and pre-clinical research.

    Robert and Renée Belfer Office for Dana-Farber Innovations (BODFI)

    BODFI facilitates the transfer of research innovations from our laboratories to the clinic and to patients through the timely commercialization of new discoveries, and by serving as a bridge between research and industry. BODFI works closely with Dana-Farber investigators, to create innovations through collaborations and productive relationships with industry.

    Learn more about Dana-Farber Innovations and BODFI

    Office of Research Integrity

    Dana-Farber's Office of Research Integrity (ORI) provides education, guidance, and administrative support to faculty and institutional leadership to prevent, mitigate, and/or manage institutional conflict of interest (ICOI). An ICOI arises when a financial interest of an institution or an institutional official, acting within his or her authority, could impact the design, conduct, or reporting of research carried out under the auspices of the institution. Dana-Farber is committed to ensuring that its research and clinical activities are conducted with integrity and without bias. As part of this commitment, Dana-Farber makes every effort to disclose the existence of institutional conflicts of interest to research participants.

    Learn more about Dana-Farber ORI and ICOI

    Innovations

    In partnership with BODFI, Dana-Farber makes publicly available a list of FDA-approved therapeutics and diagnostics in which the Institute has a financial interest.

    Institutional financial interests in pre-approved technologies are disclosed to research participants on an as-needed basis in connection with specific studies.

    View a publicly available list of FDA-approved therapeutics and diagnostics from which Dana-Farber receives royalty income

    Contact

    If you have questions about the contents of this website, BODFI Innovations, Dana-Farber ORI, or Dana-Farber ICOI, you may reach either BODFI or ORI at the following offices:

    The Robert and Renée Belfer Office for Dana-Farber Innovations (BODFI)

    Phone: 617-632-5807
    Email: innovation@dfci.harvard.edu
    450 Brookline Avenue, BP 304
    Boston, MA 02215

    Dana-Farber Cancer Institute's Office of Research Integrity (ORI)

    Phone: 617-582-8302
    Email: researchintegrity@dfci.harvard.edu
    450 Brookline Avenue, BP2101A
    Boston, MA 02215